Posted 1/16/2011 3:40 AM (GMT 0)
Hi there, Northernguy... You and I share that feeling of disappointment! I believe we were in the trial about the same time... There is someone on the board right now who just started it a month or so ago. They restarted and ... sad for you and I, but good for new trial entries, is that the 610 arm is now an open-label. :-( I called Osiris and they said that I've already participated in the trial, so I cannot get open label, which we had (if we responded in 603) but ours was re-randomized.
However, the new open label is only 8 treatments, not continuous as needed until approved. Or even for 2 years to come. Just the 2 more series of infusions over a 2 year span.
Osiris has submitted to FDA (I think!) for GvH disease, not sure how that's going to turn out. Technically their poor trial design really flawed (in my opinion) the results. I just hope they can pull off an approval! They did tell me they have about ~110-120 patients left to enroll. They do not need to gather 2 years of data on those ~110-120 participants, just 30 days worth. So they were hoping to get a submission ready in a year and a half or so. Still fast track, so we should know ... one day. Love to hear updates from anyone else with more recent contact.